Alkem Laboratories Discontinued
FDA Approved Drugs

Alkem Laboratories Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 10
  • Latest Approval Date Nov 28, 2023
  • Data Source FDA
  • First Approval Date Jun 24, 2015
All
357
View
Unclassified
2
View
Discontinued
10
View
RX
345
View
Company Overview

Company

Alkem Laboratories Discontinued

Country

India

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Alkem Laboratories Discontinued

Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013

India

www.alkemlabs.com/ contact@alkem.com View on Map
FDA Approved Drug Records ( 10 records )
2023
28 Nov
Discontinued Application: 213782

Drug Name

BREXPIPRAZOLE

Product Number

1

Dosage Form

-

Strength

0.25MG

Approval Date

2023-11-28

213782 / 1

Active Ingredient

BREXPIPRAZOLE

Application Number

213782

Product Number

1

Dosage Form

-

Strength

0.25MG

Approval Date

2023-11-28

Regulatory Status

Discontinued

2023
28 Nov
Discontinued Application: 213782

Drug Name

BREXPIPRAZOLE

Product Number

2

Dosage Form

-

Strength

0.5MG

Approval Date

2023-11-28

213782 / 2

Active Ingredient

BREXPIPRAZOLE

Application Number

213782

Product Number

2

Dosage Form

-

Strength

0.5MG

Approval Date

2023-11-28

Regulatory Status

Discontinued

2023
28 Nov
Discontinued Application: 213782

Drug Name

BREXPIPRAZOLE

Product Number

3

Dosage Form

-

Strength

1MG

Approval Date

2023-11-28

213782 / 3

Active Ingredient

BREXPIPRAZOLE

Application Number

213782

Product Number

3

Dosage Form

-

Strength

1MG

Approval Date

2023-11-28

Regulatory Status

Discontinued

2023
28 Nov
Discontinued Application: 213782

Drug Name

BREXPIPRAZOLE

Product Number

4

Dosage Form

-

Strength

2MG

Approval Date

2023-11-28

213782 / 4

Active Ingredient

BREXPIPRAZOLE

Application Number

213782

Product Number

4

Dosage Form

-

Strength

2MG

Approval Date

2023-11-28

Regulatory Status

Discontinued

2023
28 Nov
Discontinued Application: 213782

Drug Name

BREXPIPRAZOLE

Product Number

5

Dosage Form

-

Strength

3MG

Approval Date

2023-11-28

213782 / 5

Active Ingredient

BREXPIPRAZOLE

Application Number

213782

Product Number

5

Dosage Form

-

Strength

3MG

Approval Date

2023-11-28

Regulatory Status

Discontinued

2023
28 Nov
Discontinued Application: 213782

Drug Name

BREXPIPRAZOLE

Product Number

6

Dosage Form

-

Strength

4MG

Approval Date

2023-11-28

213782 / 6

Active Ingredient

BREXPIPRAZOLE

Application Number

213782

Product Number

6

Dosage Form

-

Strength

4MG

Approval Date

2023-11-28

Regulatory Status

Discontinued

2015
24 Jun
Discontinued Application: 203741

Drug Name

NEBIVOLOL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 2.5MG BASE

Approval Date

2015-06-24

203741 / 1

Active Ingredient

NEBIVOLOL HYDROCHLORIDE

Application Number

203741

Product Number

1

Dosage Form

-

Strength

EQ 2.5MG BASE

Approval Date

2015-06-24

Regulatory Status

Discontinued

2015
24 Jun
Discontinued Application: 203741

Drug Name

NEBIVOLOL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2015-06-24

203741 / 2

Active Ingredient

NEBIVOLOL HYDROCHLORIDE

Application Number

203741

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2015-06-24

Regulatory Status

Discontinued

2015
24 Jun
Discontinued Application: 203741

Drug Name

NEBIVOLOL HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2015-06-24

203741 / 3

Active Ingredient

NEBIVOLOL HYDROCHLORIDE

Application Number

203741

Product Number

3

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2015-06-24

Regulatory Status

Discontinued

2015
24 Jun
Discontinued Application: 203741

Drug Name

NEBIVOLOL HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2015-06-24

203741 / 4

Active Ingredient

NEBIVOLOL HYDROCHLORIDE

Application Number

203741

Product Number

4

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2015-06-24

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    20 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    357 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
10 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

BREXPIPRAZOLE

Application Number

213782

Product Number

1

Active Ingredient

BREXPIPRAZOLE

Dosage Form

-

Strength

0.25MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.